Answers are grounded in this paper and cite their sources.
Hidradenitis suppurativa (HS) is associated with increased cardiovascular disease (CVD) risk. Systemic immune inflammation index (SII), neutrophil/lymphocyte (NLR), platelet/lymphocyte (PLR) and monocyte/lymphocyte ratios (MLR) are biomarkers of systemic inflammation and CVD. One small study identified a lower NLR and PLR in patients treated with adalimumab.
No takes yet. Share an insight, caveat, or question.
Kearney et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: